Epigenetics: spotlight on type 2 diabetes and obesity

Journal of Endocrinological Investigation

Volumn 39, Issue 10, 2016, Pages 1095-1103

  Desiderio, A ^a,b   Spinelli, R ^a,b   Ciccarelli, M ^a,b   Nigro, C ^a,b   Miele, C ^a,b   Beguinot, F ^a,b   Raciti, G A ^a,b  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

DNA methylation; Epigenetics; Obesity; Type 2 diabetes

Indexed keywords

UNTRANSLATED RNA;

DNA METHYLATION; EPIGENETICS; GENE FUNCTION; GENETIC ASSOCIATION; HISTONE MODIFICATION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITION; OBESITY; REVIEW; GENETIC EPIGENESIS; GENETICS;

DIABETES MELLITUS, TYPE 2; EPIGENESIS, GENETIC; HUMANS; OBESITY;

EID: 84987880320     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-016-0473-1     Document Type: Review

References (86)

1. Rappaport SM, Smith MT (2010) Epidemiology. Environment and disease risks. Science 330:460–461
2. Holliday R (2006) Epigenetics: a historical overview. Epigenetics 1:76–80
3. Waddington CH (1942) The epigenotype. Endeavour 1:18–20
4. Dupont C, Armant DR, Brenner CA (2009) Epigenetics: definition, mechanisms and clinical perspective. Semin Reprod Med 27:351–357
5. Davis TL, Yang GJ, McCarrey JR, Bartolomei MS (2000) The H19 methylation imprint is erased and re-established differentially on the parental alleles during male germ cell development. Hum Mol Genet 9:2885–2894
6. Bollati V, Baccarelli A (2010) Environmental epigenetics. Heredity 105(1):105–112
7. Tyson FL, Heindel J (2005) Environmental Influences on Epigenetic Regulation. Environ Health Perspect 113:A839
8. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl):245–254
9. Raciti GA, Nigro C, Longo M et al (2014) Personalized medicine and type 2 diabetes: lesson from epigenetics. Epigenomics 6:229–238
10. Egger G, Liang G, Aparicio A, Jones PA (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429:457–463
11. Sun C, Burgner DP, Ponsonby AL et al (2013) Effects of early-life environment and epigenetics on cardiovascular disease risk in children: highlighting the role of twin studies. Pediatr Res 73:523–530
12. Esteller M (2008) Epigenetics in cancer. N Engl J Med 358:1148–1159
13. Coulondre C, Miller JH, Farabaugh PJ, Gilbert W (1978) Molecular basis of base substitution hotspots in Escherichia coli. Nature 274:775–780
14. Gonzalgo ML, Jones PA (1997) Mutagenic and epigenetic effects of DNA methylation. Mutat Res 386:107–118
15. Li E (2002) Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 3:662–673
16. Reik W, Dean W, Walter J (2001) Epigenetic reprogramming in mammalian development. Science 293:1089–1093
17. Klose RJ, Bird AP (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31:89–97
18. Smith ZD, Meissner A (2013) DNA methylation: roles in mammalian development. Nat Rev Genet 14:204–220
19. Deaton AM, Bird A (2011) CpG islands and the regulation of transcription. Genes Dev 25:1010–1022
20. Mohn F, Weber M, Rebhan M et al (2008) Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell 30:755–766
21. Payer B, Lee JT (2008) X chromosome dosage compensation: how mammals keep the balance. Annu Rev Genet 42:733–772
22. Luger K (2001). Nucleosomes: Structure and Function. Encyclopedia of Life Sciences 1–8
23. Cooper GM (2000) The Cell: A Molecular Approach. 2nd edition. Sunderland (MA): Sinauer Associates. Chromosomes and Chromatin. Available from: http://www.ncbi.nlm.nih.gov/books/NBK9863/
24. Ma J (2005) Crossing the line between activation and repression. Trends Genet 21:54–59
25. Richards EJ, Elgin SC (2002) Epigenetic codes for heterochromatin formation and silencing: rounding up the usual suspects. Cell 108:489–500
26. Kouzarides T (2007) Chromatin modifications and their function. Cell 128:693–705
27. Tamaru H (2010) Confining euchromatin/heterochromatin territory: jumonji crosses the line. Genes Dev 24:1465–1478
28. Seol JH, Kim HJ, Yang YJ et al (2006) Different roles of histone H3 lysine 4 methylation in chromatin maintenance. Biochem Biophys Res Commun 349:463–470
29. Costa FF (2008) Non-coding RNAs, epigenetics and complexity. Gene 410:9–17
30. Mattick JS, Makunin IV (2006) Non-coding RNA. Hum Mol Genet 15 Spec No 1:R17–29
31. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
32. Londin E, Loher P, Telonis AG et al (2015) Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci USA 112:E1106–E1115
33. Mattick JS, Makunin IV (2005) Small regulatory RNAs in mammals. Hum Mol Genet 14 Spec No 1:R121–132
34. Guo X, Zhang Z, Gerstein MB, Zheng D (2009) Small RNAs originated from pseudogenes: cis- or trans-acting? PLoS Comput Biol 5:e1000449
35. Wienholds E, Plasterk RH (2005) MicroRNA function in animal development. FEBS Lett 579:5911–5922
36. Vrba L, Muñoz-Rodríguez JL, Stampfer MR, Futscher BW (2013) miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer. PLoS One 8:e54398
37. Sato F, Tsuchiya S, Meltzer SJ, Shimizu K (2011) MicroRNAs and epigenetics. FEBS J 278:1598–1609
38. International Diabetes Federation. Diabetes Atlas 6th ed, 2013 Brussels, Belgium: International Diabetes Federation, 2014
39. Ng M, Fleming T, Robinson M et al (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384:766–781
40. InterAct Consortium et al (2013) The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia 56:60–69
41. Meigs JB, Cupples LA, Wilson PW (2000) Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes 49:2201–2207
42. Klein BE, Klein R, Moss SE, Cruickshanks KJ (1996) Parental history of diabetes in a population-based study. Diabetes Care 19:827–830
43. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE (1990) The body-mass index of twins who have been reared apart. N Engl J Med 322:1483–1487
44. Rice T, Pérusse L, Bouchard C, Rao DC (1999) Familial aggregation of body mass index and subcutaneous fat measures in the longitudinal Québec family study. Genet Epidemiol 16:316–334
45. Segal NL, Allison DB (2002) Twins and virtual twins: bases of relative body weight revisited. Int J Obes Relat Metab Disord 26:437–441
46. Grarup N, Sandholt CH, Hansen T, Pedersen O (2014) Genetic susceptibility to type 2 diabetes and obesity: from genome-wide association studies to rare variants and beyond. Diabetologia 57:1528–1541
47. Al-Azzam SI, Khabour OF, Alzoubi KH, Alzayadeen RN (2014) The effect of leptin promoter and leptin receptor gene polymorphisms on lipid profile among the diabetic population: modulations by atorvastatin treatment and environmental factors. J Endocrinol Invest 37(9):835–842
48. Drong AW, Lindgren CM, McCarthy MI (2012) The genetic and epigenetic basis of type 2 diabetes and obesity. Clin Pharmacol Ther 92:707–715
49. Bloom JS, Ehrenreich IM, Loo WT, Lite TL, Kruglyak L (2013) Finding the sources of missing heritability in a yeast cross. Nature 494(7436):234–237
50. Jirtle RL, Skinner MK (2007) Environmental epigenomics and disease susceptibility. Nat Rev Genet 8:253–262
51. Cropley JE, Suter CM, Beckman KB, Martin DI (2006) Germ-line epigenetic modification of the murine A vy allele by nutritional supplementation. Proc Natl Acad Sci U S A 103:17308–17312
52. Saad MI, Abdelkhalek TM, Haiba MM, Saleh MM, Hanafi MY, Tawfik SH, Kamel MA (2016) Maternal obesity and malnourishment exacerbate perinatal oxidative stress resulting in diabetogenic programming in F1 offspring. J Endocrinol Invest 39(6):643–655
53. Speakman JR, O’Rahilly S (2012) Fat: an evolving issue. Dis Model Mech 5:569–573
54. Castillo-Fernandez JE, Spector TD, Bell JT (2014) Epigenetics of discordant monozygotic twins: implications for disease. Genome Med 6:60
55. Poulsen P, Esteller M, Vaag A, Fraga MF (2007) The epigenetic basis of twin discordance in age-related diseases. Pediatr Res 61:38R–42R
56. Lyssenko V, Laakso M (2015) Genetic Screening for the Risk of Type 2 Diabetes: worthless or valuable? Diabetes Care 36:S120–S126
57. Raciti GA, Longo M, Parrillo L et al (2015) Understanding type 2 diabetes: from genetics to epigenetics. Acta Diabetol 52(5):821–827
58. Ling C, Del Guerra S, Lupi R et al (2008) Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 51:615–622
59. Barrès R, Osler ME, Yan J et al (2009) Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab 10:189–198
60. Barres R, Kirchner H, Rasmussen M et al (2013) Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep 3:1020–1027
61. Velho G, Robert JJ (2002) Maturity-onset diabetes of the young (MODY): genetic and clinical characteristics. Horm Res 57(Suppl 1):29–33
62. Ahlgren U, Jonsson J, Jonsson L, Simu K, Edlund H (1998) beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev 12:1763–1768
63. Yang BT, Dayeh TA, Volkov PA et al (2012) Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Mol Endocrinol 26:1203–1212
64. Toperoff G, Aran D, Kark JD et al (2012) Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet 21:371–383
65. Jung UJ, Choi MS (2014) Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci 15(4):6184–6223
66. Shen W, Wang C, Xia L et al (2014) Epigenetic modification of the leptin promoter in diet-induced obese mice and the effects of N-3 polyunsaturated fatty acids. Sci Rep 4:5282
67. Cifani C, Micioni Di Bonaventura MV et al (2015) Regulation of hypothalamic neuropeptides gene expression in diet induced obesity resistant rats: possible targets for obesity prediction? Front Neurosci 9:187
68. Dolinoy DC (2008) The agouti mouse model: an epigenetic biosensor for nutritional and environmental alterations on the fetal epigenome. Nutr Rev 66(Suppl 1):S7–11
69. Cooney CA, Dave AA, Wolff GL (2002) Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 132:2393S–2400S
70. Wolff GL, Kodell RL, Moore SR, Cooney CA (1998) Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 12:949–957
71. Ling C, Groop L (2009) Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 58:2718–2725
72. Kuehnen P, Mischke M, Wiegand S et al (2012) An Alu element-associated hypermethylation variant of the POMC gene is associated with childhood obesity. PLoS Genet 8:e1002543
73. Reddy MA, Natarajan R (2015) Recent developments in epigenetics of acute and chronic kidney diseases. Kidney Int 88:250–261
74. Godfrey KM, Sheppard A, Gluckman PD et al (2011) Epigenetic gene promoter methylation at birth is associated with child’s later adiposity. Diabetes 60(5):1528–1534
75. Campión J, Milagro FI, Martínez JA (2009) Individuality and epigenetics in obesity. Obes Rev 10:383–392
76. Seki Y, Williams L, Vuguin PM, Charron MJ (2012) Minireview: epigenetic programming of diabetes and obesity: animal models. Endocrinology 153:1031–1038
77. Parrillo L, Costa V, Raciti G.A.,Longo M.,Spinelli R.,Esposito R.,Nigro C., Vastolo V., Desiderio A., Zatterale F., Ciccodicola A., Formisano P., Miele C. Beguinot F. et al (2016) Hoxa5 undergoes dynamic DNA methylation and transcriptional repression in the adipose tissue of mice exposed to high-fat diet. Int J obesity. 40(6). pp: 929-937. DOI: 10.1038/ijo.2016.36.
78. Cowherd RM, Lyle RE, Miller CP, Mcgehee RE Jr (1997) Developmental profile of homeobox gene expression during 3T3-L1 adipogenesis. Biochem Biophys Res Commun 237:470–475
79. Charlier C, Segers K, Karim L et al (2001) The callipyge mutation enhances the expression of coregulated imprinted genes in cis without affecting their imprinting status. Nat Genet 27:367–369
80. Dong C, Li WD, Geller F et al (2005) Possible genomic imprinting of three human obesity-related genetic loci. Am J Hum Genet 76:427–437
81. Bera TK, Liu XF, Yamada M et al (2008) A model for obesity and gigantism due to disruption of the Ankrd26 gene. Proc Natl Acad Sci USA 105:270–275
82. Raciti GA, Bera TK, Gavrilova O, Pastan I (2011) Partial inactivation of Ankrd26 causes diabetes with enhanced insulin responsiveness of adipose tissue in mice. Diabetologia 54:2911–2922
83. Acs P, Bauer PO, Mayer B et al (2015) A novel form of ciliopathy underlies hyperphagia and obesity in Ankrd26 knockout mice. Brain Struct Funct 220:1511–1528
84. Fei Z, Bera TK, Liu X, Xiang L, Pastan I (2011) Ankrd26 gene disruption enhances adipogenesis of mouse embryonic fibroblasts. J Biol Chem 286:27761–27768
85. Liu XF, Bera TK, Kahue C et al (2012) ANKRD26 and its interacting partners TRIO, GPS2, HMMR and DIPA regulate adipogenesis in 3T3-L1 cells. PLoS ONE 7:e38130
86. Rönn T, Volkov P, Gillberg L et al (2015) Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood. Hum Mol Genet 24:3792–3813